A Trusted Partner Providing
Reliable Information on Medicines

  • slide
  • slide
  • slide
  • slide
App Store Google Play

News


Sep 18, 2025, 9:38 PM

AZCERT’s MedSafetyScan – an online QT/ torsades de pointes patient risk assessment tool – was the subject of a recently published scientific paper, whose results provide strong validation for our model.

View post
May 22, 2025, 6:24 PM

AZCERT's Scientific Review Committee has found substantial evidence that Bilastine (antihistamine) and Gepotidacin (antibiotic) are associated with the development of QT prolongation but lack convincing evidence of causing torsades de pointes (TdP).…

View post
Apr 3, 2025, 7:22 PM

AZCERT today unveiled a critically important update to its CredibleMeds® mobile app, a revolutionary tool designed to help healthcare providers and patients navigate the complex world of medication safety. This comprehensive mobile application…

View post
Dec 2, 2024, 10:03 PM

AZCERT's Scientific Review Committee has found substantial evidence that Opipramol (antidepressant), Revumenib (anticancer) and Sitafloxacin (antibiotic) are associated with the development of QT prolongation but lack convincing evidence of causing…

View post
Aug 14, 2024, 6:26 AM

August changes to the QTdrugs List and List of Drugs to Avoid in cLQTS

View post

Text for citing the use of the QTdrugs List or the CredibleMeds.org website:

Woosley RL, Heise CW, Gallo T, Woosley RD, Lambson J. and Romero KA,  www.CredibleMeds.org,  QTdrugs List, [Accession Date], AZCERT, 1457 E. Desert Garden Dr., Tucson, AZ  85718

 

Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.

x